Other Species / Isoforms
  AP2B1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T2-p
______MtDskyFTT
Upstream
0 3
Treatment
  • FGF1
  • PD173074
AP2B1 (human) ______MtDskyFTT T2-p
AP2B1 iso2 (human) ______MTDSKYFTT T2
AP2B1 (mouse) ______MtDskYFTT T2-p
AP2B1 (rat) ______MTDSkYFTT T2
S4-p
____MtDskyFTTNk
Upstream
0 4
Treatment
  • HB-EGF
  • LPA
AP2B1 (human) ____MtDskyFTTNk S4-p
AP2B1 iso2 (human) ____MTDSKYFTTNK S4
AP2B1 (mouse) ____MtDskYFTTNK S4-p
AP2B1 (rat) ____MTDSkYFTTNK S4
K5
___MtDsKyFTTNkk
0 2
AP2B1 (human) ___MtDsKyFTTNkk K5
AP2B1 iso2 (human) ___MTDSKYFTTNKK K5
AP2B1 (mouse) ___MtDskYFTTNKk K5-ac
AP2B1 (rat) ___MTDSkYFTTNKK K5-ac
K5-ub
___MtDskyFTTNkk
0 3
AP2B1 (human) ___MtDskyFTTNkk K5-ub
AP2B1 iso2 (human) ___MTDSKYFTTNKK K5
AP2B1 (mouse) ___MtDsKYFTTNKk K5
AP2B1 (rat) ___MTDSKYFTTNKK K5
Y6-p
__MtDskyFTTNkkG
Upstream
1 20
Treatment
  • EGF
  • FGF1
  • PD173074
AP2B1 (human) __MtDskyFTTNkkG Y6-p
AP2B1 iso2 (human) __MTDSKYFTTNKKG Y6
AP2B1 (mouse) __MtDskYFTTNKkG Y6
AP2B1 (rat) __MTDSkYFTTNKKG Y6
K11-ub
skyFTTNkkGEIFEL
0 1
AP2B1 (human) skyFTTNkkGEIFEL K11-ub
AP2B1 iso2 (human) SKYFTTNKKGEIFEL K11
AP2B1 (mouse) skYFTTNKkGEIFEL K11
AP2B1 (rat) SkYFTTNKKGEIFEL K11
K12-ub
kyFTTNkkGEIFELk
0 5
AP2B1 (human) kyFTTNkkGEIFELk K12-ub
AP2B1 iso2 (human) KYFTTNKKGEIFELK K12
AP2B1 (mouse) kYFTTNKkGEIFELK K12-ub
AP2B1 (rat) kYFTTNKKGEIFELK K12
K19-ac
kGEIFELkAELNNEk
0 1
AP2B1 (human) kGEIFELkAELNNEk K19-ac
AP2B1 iso2 (human) KGEIFELKAELNNEK K19
AP2B1 (mouse) kGEIFELKAELNNEK K19
AP2B1 (rat) KGEIFELKAELNNEK K19
K19-ub
kGEIFELkAELNNEk
0 1
AP2B1 (human) kGEIFELkAELNNEk K19-ub
AP2B1 iso2 (human) KGEIFELKAELNNEK K19
AP2B1 (mouse) kGEIFELKAELNNEK K19
AP2B1 (rat) KGEIFELKAELNNEK K19
K26-ac
kAELNNEkKEKRKEA
0 1
AP2B1 (human) kAELNNEkKEKRKEA K26-ac
AP2B1 iso2 (human) KAELNNEKKEKRKEA K26
AP2B1 (mouse) KAELNNEKKEKRKEA K26
AP2B1 (rat) KAELNNEKKEKRKEA K26
T42
KKVIAAMTVGKDVSS
0 1
AP2B1 (human) KKVIAAMTVGKDVSS T42
AP2B1 iso2 (human) KKVIAAMTVGKDVSS T42
AP2B1 (mouse) KKVIAAMtVGKDVSS T42-p
AP2B1 (rat) KKVIAAMTVGKDVSS T42
S90-p
MAIMAVNsFVKDCED
0 1
AP2B1 (human) MAIMAVNsFVKDCED S90-p
AP2B1 iso2 (human) MAIMAVNSFVKDCED S90
AP2B1 (mouse) MAIMAVNSFVKDCED S90
AP2B1 (rat) MAIMAVNSFVKDCED S90
K117-ub
MGCIRVDkITEYLCE
0 5
AP2B1 (human) MGCIRVDkITEYLCE K117-ub
AP2B1 iso2 (human) MGCIRVDKITEYLCE K117
AP2B1 (mouse) MGCIRVDkITEYLCE K117-ub
AP2B1 (rat) MGCIRVDKITEYLCE K117
K131-ub
EPLRKCLkDEDPyVR
0 9
AP2B1 (human) EPLRKCLkDEDPyVR K131-ub
AP2B1 iso2 (human) EPLRKCLKDEDPYVR K131
AP2B1 (mouse) EPLRKCLkDEDPyVR K131-ub
AP2B1 (rat) EPLRKCLKDEDPYVR K131
Y136-p
CLkDEDPyVRkTAAV
0 26
AP2B1 (human) CLkDEDPyVRkTAAV Y136-p
AP2B1 iso2 (human) CLKDEDPYVRKTAAV Y136
AP2B1 (mouse) CLkDEDPyVRKTAAV Y136-p
AP2B1 (rat) CLKDEDPYVRKTAAV Y136
K139-ub
DEDPyVRkTAAVCVA
0 2
AP2B1 (human) DEDPyVRkTAAVCVA K139-ub
AP2B1 iso2 (human) DEDPYVRKTAAVCVA K139
AP2B1 (mouse) DEDPyVRKTAAVCVA K139
AP2B1 (rat) DEDPYVRKTAAVCVA K139
K147-ub
TAAVCVAkLHDINAQ
0 1
AP2B1 (human) TAAVCVAkLHDINAQ K147-ub
AP2B1 iso2 (human) TAAVCVAKLHDINAQ K147
AP2B1 (mouse) TAAVCVAKLHDINAQ K147
AP2B1 (rat) TAAVCVAKLHDINAQ K147
T245-p
QSICERVtPRLsHAN
0 4
AP2B1 (human) QSICERVtPRLsHAN T245-p
AP2B1 iso2 (human) QSICERVTPRLSHAN T245
AP2B1 (mouse) QSICERVTPRLsHAN T245
AP2B1 (rat) QSICERVTPRLSHAN T245
S249-p
ERVtPRLsHANSAVV
0 4
AP2B1 (human) ERVtPRLsHANSAVV S249-p
AP2B1 iso2 (human) ERVTPRLSHANSAVV S249
AP2B1 (mouse) ERVTPRLsHANSAVV S249-p
AP2B1 (rat) ERVTPRLSHANSAVV S249
S258-p
ANSAVVLsAVKVLMk
Upstream
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
Putative in vivo kinases:
  • PRKD1 (human)
Treatment
  • CRT0066101
  • siRNA
AP2B1 (human) ANSAVVLsAVKVLMk S258-p
AP2B1 iso2 (human) ANSAVVLSAVKVLMK S258
AP2B1 (mouse) ANSAVVLsAVKVLMk S258-p
AP2B1 (rat) ANSAVVLSAVKVLMk S258
K265-ac
sAVKVLMkFLELLPk
0 3
AP2B1 (human) sAVKVLMkFLELLPk K265-ac
AP2B1 iso2 (human) SAVKVLMKFLELLPK K265
AP2B1 (mouse) sAVKVLMkFLELLPk K265-ac
AP2B1 (rat) SAVKVLMkFLELLPk K265-ac
K265
sAVKVLMKFLELLPk
0 1
AP2B1 (human) sAVKVLMKFLELLPk K265
AP2B1 iso2 (human) SAVKVLMKFLELLPK K265
AP2B1 (mouse) sAVKVLMkFLELLPk K265-ub
AP2B1 (rat) SAVKVLMKFLELLPk K265
K272
kFLELLPKDsDyyNM
0 1
AP2B1 (human) kFLELLPKDsDyyNM K272
AP2B1 iso2 (human) KFLELLPKDSDYYNM K272
AP2B1 (mouse) kFLELLPKDSDyYNM K272
AP2B1 (rat) kFLELLPkDSDYYNM K272-ac
K272-ub
kFLELLPkDsDyyNM
0 3
AP2B1 (human) kFLELLPkDsDyyNM K272-ub
AP2B1 iso2 (human) KFLELLPKDSDYYNM K272
AP2B1 (mouse) kFLELLPkDSDyYNM K272-ub
AP2B1 (rat) kFLELLPKDSDYYNM K272
S274-p
LELLPkDsDyyNMLL
0 1
AP2B1 (human) LELLPkDsDyyNMLL S274-p
AP2B1 iso2 (human) LELLPKDSDYYNMLL S274
AP2B1 (mouse) LELLPkDSDyYNMLL S274
AP2B1 (rat) LELLPkDSDYYNMLL S274
Y276-p
LLPkDsDyyNMLLkK
Upstream
0 50
Regulatory protein:
  • CSFR (human)
Treatment
  • ephrin_B1
  • ephrin_B2
AP2B1 (human) LLPkDsDyyNMLLkK Y276-p
AP2B1 iso2 (human) LLPKDSDYYNMLLKK Y276
AP2B1 (mouse) LLPkDSDyYNMLLkk Y276-p
AP2B1 (rat) LLPkDSDYYNMLLkK Y276
Y277-p
LPkDsDyyNMLLkKL
Upstream
Downstream
1 8
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Putative in vivo kinases:
  • PRKD1 (human)
Regulatory protein:
  • CSFR (human)
Treatment
  • CRT0066101
  • siRNA
AP2B1 (human) LPkDsDyyNMLLkKL Y277-p
AP2B1 iso2 (human) LPKDSDYYNMLLKKL Y277
AP2B1 (mouse) LPkDSDyYNMLLkkL Y277
AP2B1 (rat) LPkDSDYYNMLLkKL Y277
K282
DyyNMLLKKLAPPLV
0 2
AP2B1 (human) DyyNMLLKKLAPPLV K282
AP2B1 iso2 (human) DYYNMLLKKLAPPLV K282
AP2B1 (mouse) DyYNMLLkkLAPPLV K282-ac
AP2B1 (rat) DYYNMLLkKLAPPLV K282-ac
K282-ub
DyyNMLLkKLAPPLV
0 1
AP2B1 (human) DyyNMLLkKLAPPLV K282-ub
AP2B1 iso2 (human) DYYNMLLKKLAPPLV K282
AP2B1 (mouse) DyYNMLLKkLAPPLV K282
AP2B1 (rat) DYYNMLLKKLAPPLV K282
K283
yyNMLLkKLAPPLVT
0 1
AP2B1 (human) yyNMLLkKLAPPLVT K283
AP2B1 iso2 (human) YYNMLLKKLAPPLVT K283
AP2B1 (mouse) yYNMLLkkLAPPLVT K283-ub
AP2B1 (rat) YYNMLLkKLAPPLVT K283
Y300-p
SGEPEVQyVALRNIN
0 1
AP2B1 (human) SGEPEVQyVALRNIN Y300-p
AP2B1 iso2 (human) SGEPEVQYVALRNIN Y300
AP2B1 (mouse) SGEPEVQYVALRNIN Y300
AP2B1 (rat) SGEPEVQYVALRNIN Y300
K318-ac
QKRPEILkQEIKVFF
0 3
AP2B1 (human) QKRPEILkQEIKVFF K318-ac
AP2B1 iso2 (human) QKRPEILKQEIKVFF K318
AP2B1 (mouse) QKRPEILkQEIKVFF K318-ac
AP2B1 (rat) QKRPEILkQEIKVFF K318-ac
K318-ub
QKRPEILkQEIKVFF
0 1
AP2B1 (human) QKRPEILkQEIKVFF K318-ub
AP2B1 iso2 (human) QKRPEILKQEIKVFF K318
AP2B1 (mouse) QKRPEILKQEIKVFF K318
AP2B1 (rat) QKRPEILKQEIKVFF K318
K327
EIKVFFVKYNDPIyV
0 2
AP2B1 (human) EIKVFFVKYNDPIyV K327
AP2B1 iso2 (human) EIKVFFVKYNDPIYV K327
AP2B1 (mouse) EIKVFFVkYNDPIYV K327-ac
AP2B1 (rat) EIKVFFVkYNDPIYV K327-ac
Y333-p
VKYNDPIyVKLEKLD
0 1
AP2B1 (human) VKYNDPIyVKLEKLD Y333-p
AP2B1 iso2 (human) VKYNDPIYVKLEKLD Y333
AP2B1 (mouse) VkYNDPIYVKLEKLD Y333
AP2B1 (rat) VkYNDPIYVKLEKLD Y333
T363-p
AELKEYAtEVDVDFV
0 1
AP2B1 (human) AELKEYAtEVDVDFV T363-p
AP2B1 iso2 (human) AELKEYATEVDVDFV T363
AP2B1 (mouse) AELKEYATEVDVDFV T363
AP2B1 (rat) AELKEYATEVDVDFV T363
S393-p
QSAERCVsTLLDLIQ
0 3
AP2B1 (human) QSAERCVsTLLDLIQ S393-p
AP2B1 iso2 (human) QSAERCVSTLLDLIQ S393
AP2B1 (mouse) QSAERCVsTLLDLIQ S393-p
AP2B1 (rat) QSAERCVSTLLDLIQ S393
Y524-p
PDLRDRGyIYWRLLS
0 1
AP2B1 (human) PDLRDRGyIYWRLLS Y524-p
AP2B1 iso2 (human) PDLRDRGYIYWRLLS Y524
AP2B1 (mouse) PDLRDRGYIYWRLLS Y524
AP2B1 (rat) PDLRDRGYIYWRLLS Y524
T536-p
LLSTDPVtAkEVVLS
0 1
AP2B1 (human) LLSTDPVtAkEVVLS T536-p
AP2B1 iso2 (human) LLSTDPVTAKEVVLS T536
AP2B1 (mouse) LLSTDPVTAkEVVLS T536
AP2B1 (rat) LLSTDPVTAKEVVLS T536
K538-ub
STDPVtAkEVVLSEK
0 3
AP2B1 (human) STDPVtAkEVVLSEK K538-ub
AP2B1 iso2 (human) STDPVTAKEVVLSEK K538
AP2B1 (mouse) STDPVTAkEVVLSEK K538-ub
AP2B1 (rat) STDPVTAKEVVLSEK K538
Y574-p
IGSLASVyHKPPNAF
0 9
AP2B1 (human) IGSLASVyHKPPNAF Y574-p
AP2B1 iso2 (human) IGSLASVYHKPPNAF Y574
AP2B1 (mouse) IGSLASVYHKPPNAF Y574
AP2B1 (rat) IGSLASVYHKPPNAF Y574
S599
HLPIHHGSTDAGDsP
0 2
AP2B1 (human) HLPIHHGSTDAGDsP S599
AP2B1 iso2 (human) HLPIHHGSTDAGDSP S599
AP2B1 (mouse) HLPIHHGsTDAGDsP S599-p
AP2B1 (rat) HLPIHHGSTDAGDSP S599
S605-p
GSTDAGDsPVGTTTA
0 6
AP2B1 (human) GSTDAGDsPVGTTTA S605-p
AP2B1 iso2 (human) GSTDAGDSPVGTTTA S605
AP2B1 (mouse) GsTDAGDsPVGtTTT S605-p
AP2B1 (rat) GSTDAGDSPVGTTTA S605
T609
AGDsPVGTTTATNLE
0 1
AP2B1 (human) AGDsPVGTTTATNLE T609
AP2B1 iso2 (human) AGDSPVGTTTATNLE T609
AP2B1 (mouse) AGDsPVGtTTTTNLE T609-p
AP2B1 (rat) AGDSPVGTTTATNLE T609
S680-p
VPATFAPsPTPAVVS
0 1
AP2B1 (human) VPATFAPsPTPAVVS S680-p
AP2B1 iso2 (human) VPATFAPSPTPAVVS S694
AP2B1 (mouse) VPATFAPSPTPAVVS S680
AP2B1 (rat) VPATFAPSPTPAVVS S680
K719
AVWLPAVKAkGLEIS
0 1
AP2B1 (human) AVWLPAVKAkGLEIS K719
AP2B1 iso2 (human) AVWLPAVKAKGLEIS K733
AP2B1 (mouse) AVWLPAVkAKGLEIS K719-ub
AP2B1 (rat) AVWLPAVKAKGLEIS K719
K721-ub
WLPAVKAkGLEISGT
0 1
AP2B1 (human) WLPAVKAkGLEISGT K721-ub
AP2B1 iso2 (human) WLPAVKAKGLEISGT K735
AP2B1 (mouse) WLPAVkAKGLEISGT K721
AP2B1 (rat) WLPAVKAKGLEISGT K721
Y737-p
THRQGHIyMEMNFTN
Upstream
Downstream
2 13
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • ADRB2 (human)
  • AT1 (human)
  • AVPR2 (human)
  • BKR2 (human)
  • EDNRA (human)
  • EGFR (human)
  • PTAFR (human)
Treatment
  • angiotensin_2
  • bradykinin
  • carbamyl-PAF
  • doxycycline
  • EGF
  • endothelin
  • isoproterenol
  • PP2
  • vasopressin
AP2B1 (human) THRQGHIyMEMNFTN Y737-p
AP2B1 iso2 (human) THRQGHIYMEMNFTN Y751
AP2B1 (mouse) THRQGHIyMEMNFTN Y737-p
AP2B1 (rat) THRQGHIYMEMNFTN Y737
T768
SFGVIPSTPLAIHTP
0 1
AP2B1 (human) SFGVIPSTPLAIHTP T768
AP2B1 iso2 (human) SFGVIPSTPLAIHTP T782
AP2B1 (mouse) SFGVIPStPLAIHTP T768-p
AP2B1 (rat) SFGVIPSTPLAIHTP T768
R834-m1
VEDGKMErQVFLAtW
0 1
AP2B1 (human) VEDGKMErQVFLAtW R834-m1
AP2B1 iso2 (human) VEDGKMERQVFLATW R848
AP2B1 (mouse) VEDGKMERQVFLATW R834
AP2B1 (rat) VEDGKMERQVFLATW R834
T840-p
ErQVFLAtWKDIPNE
0 1
AP2B1 (human) ErQVFLAtWKDIPNE T840-p
AP2B1 iso2 (human) ERQVFLATWKDIPNE T854
AP2B1 (mouse) ERQVFLATWkDIPNE T840
AP2B1 (rat) ERQVFLATWKDIPNE T840
K842
QVFLAtWKDIPNENE
0 1
AP2B1 (human) QVFLAtWKDIPNENE K842
AP2B1 iso2 (human) QVFLATWKDIPNENE K856
AP2B1 (mouse) QVFLATWkDIPNENE K842-ac
AP2B1 (rat) QVFLATWKDIPNENE K842
K855-ub
NELQFQIkECHLNAD
0 3
AP2B1 (human) NELQFQIkECHLNAD K855-ub
AP2B1 iso2 (human) NELQFQIKECHLNAD K869
AP2B1 (mouse) NELQFQIKECHLNAD K855
AP2B1 (rat) NELQFQIKECHLNAD K855
K867-ub
NADTVSSkLQNNNVy
0 2
AP2B1 (human) NADTVSSkLQNNNVy K867-ub
AP2B1 iso2 (human) NADTVSSKLQNNNVY K881
AP2B1 (mouse) NADTVSSKLQNNNVY K867
AP2B1 (rat) NADTVSSKLQNNNVy K867
Y874-p
kLQNNNVyTIAkRNV
0 3
AP2B1 (human) kLQNNNVyTIAkRNV Y874-p
AP2B1 iso2 (human) KLQNNNVYTIAKRNV Y888
AP2B1 (mouse) KLQNNNVYTIAkRNV Y874
AP2B1 (rat) KLQNNNVyTIAKRNV Y874-p
K878-ub
NNVyTIAkRNVEGQD
0 5
AP2B1 (human) NNVyTIAkRNVEGQD K878-ub
AP2B1 iso2 (human) NNVYTIAKRNVEGQD K892
AP2B1 (mouse) NNVYTIAkRNVEGQD K878-ub
AP2B1 (rat) NNVyTIAKRNVEGQD K878
Y888-p
VEGQDMLyQSLKLTN
1 51
AP2B1 (human) VEGQDMLyQSLKLTN Y888-p
AP2B1 iso2 (human) VEGQDMLYQSLKLTN Y902
AP2B1 (mouse) VEGQDMLyQSLKLTN Y888-p
AP2B1 (rat) VEGQDMLyQSLKLTN Y888-p
K917-ub
PNYTLSLkCRAPEVS
0 2
AP2B1 (human) PNYTLSLkCRAPEVS K917-ub
AP2B1 iso2 (human) PNYTLSLKCRAPEVS K931
AP2B1 (mouse) PNYTLSLKCRAPEVS K917
AP2B1 (rat) PNYTLSLKCRAPEVS K917
Y926-p
RAPEVSQyIyQVYDS
0 2
AP2B1 (human) RAPEVSQyIyQVYDS Y926-p
AP2B1 iso2 (human) RAPEVSQYIYQVYDS Y940
AP2B1 (mouse) RAPEVSQYIyQVyDS Y926
AP2B1 (rat) RAPEVSQyIyQVYDS Y926-p
Y928-p
PEVSQyIyQVYDSIL
0 33
AP2B1 (human) PEVSQyIyQVYDSIL Y928-p
AP2B1 iso2 (human) PEVSQYIYQVYDSIL Y942
AP2B1 (mouse) PEVSQYIyQVyDSIL Y928-p
AP2B1 (rat) PEVSQyIyQVYDSIL Y928-p
Y931
SQyIyQVYDSILKN_
0 1
AP2B1 (human) SQyIyQVYDSILKN_ Y931
AP2B1 iso2 (human) SQYIYQVYDSILKN_ Y945
AP2B1 (mouse) SQYIyQVyDSILKN_ Y931-p
AP2B1 (rat) SQyIyQVYDSILKN_ Y931